SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 108.51 |
| Enterprise Value ($M) | 28.31 |
| Book Value ($M) | 22.73 |
| Book Value / Share | 2.02 |
| Price / Book | 4.77 |
| NCAV ($M) | 10.43 |
| NCAV / Share | 0.93 |
| Price / NCAV | 10.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.33 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | -0.54 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.42 |
| Current Ratio | 1.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 86.15 |
| Assets | 98.45 |
| Liabilities | 75.72 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Allostery Investments LP | 0.50 | -28.64 | |
| 13G | Orbimed Advisors Llc | 9.90 | ||
| 13G/A | Crutcher Patrick J | 5.60 | 395.68 | |
| 13G | Ikarian Capital, LLC | 10.02 | ||
| 13G | Ra Capital Management, L.p. | 9.99 | ||
| 13G | Biotechnology Value Fund L P | 9.99 | ||
| 13G | Emerald Bioventures, LLC | 5.60 | ||
| 13G | Deep Track Capital, LP | 9.99 | ||
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 0.00 | -100.00 | |
| 13G/A | Nantahala Capital Management, LLC | 4.90 | -93.57 | |
| 13G/A | Great Point Partners Llc | 0.26 | ||
| 13G/A | Point72 Asset Management, L.P. | 0.30 | -99.96 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 21,219 | 80,071 | 26.50 | |
| 5,979 | 87,994 | 6.79 | |
| 4,005 | 48,898 | 8.19 | |
| 5,156 | 62,173 | 8.29 | |
| 3,784 | 28,244 | 13.40 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATOS – Atossa Therapeutics, Inc. | ATXI – Avenue Therapeutics, Inc. |
| ATYR – aTyr Pharma, Inc. | AWH – Aspira Women's Health Inc. |
| AYTU – Aytu BioPharma, Inc. |
Financial data and stock pages provided by
Fintel.io